<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The acquisition of secondary chromosomal aberrations in <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>) patients with <z:e sem="disease" ids="C0856536" disease_type="Neoplastic Process" abbrv="">Philadelphia chromosome-positive</z:e> (Ph+) karyotype signifies <z:e sem="disease" ids="C1516669" disease_type="Neoplastic Process" abbrv="">clonal evolution</z:e> associated with the progression of the disease to its accelerated or <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blastic phase</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, these aberrations have clinical and biological significance </plain></SENT>
<SENT sid="2" pm="."><plain>T(3;12)(q26;p13), which is a recurrent chromosomal aberration observed in <z:e sem="disease" ids="C0027022" disease_type="Neoplastic Process" abbrv="MPD">myeloid malignancies</z:e>, is typically associated with <z:mpath ids='MPATH_589'>dysplasia</z:mpath> of megakaryocytes, multilineage involvement, short duration of any <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blastic phase</z:e>, and extremely poor prognosis </plain></SENT>
<SENT sid="3" pm="."><plain>We have identified a recurrent reciprocal translocation between chromosomes 3 and 12 with different breakpoint at bands 3q21 in the malignant cells from a 28-year-old man </plain></SENT>
<SENT sid="4" pm="."><plain>The patient was initially diagnosed as having Ph+ <z:mp ids='MP_0005481'>CML</z:mp> in the <z:hpo ids='HP_0011010'>chronic</z:hpo> phase </plain></SENT>
<SENT sid="5" pm="."><plain>The t(3;12)(q21;p13) translocation occurred 4 years after the patient was first diagnosed with <z:mp ids='MP_0005481'>CML</z:mp> while undergoing <z:chebi fb="0" ids="38637">tyrosine kinase inhibitor</z:chebi> therapy </plain></SENT>
<SENT sid="6" pm="."><plain>We confirmed the t(3;12)(q21;p13) translocation via fluorescence in situ hybridization assay by using whole-chromosome paint probes for chromosomes 3 and 12 </plain></SENT>
<SENT sid="7" pm="."><plain>Our findings demonstrate that, similar to other recurrent translocations involving 3q26 such as t(3;3) and t(3;21), the t(3;12)(q21;p13) translocation is implicated not only in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> but also in the progression of <z:mp ids='MP_0005481'>CML</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>These findings extend the disease spectrum of this cytogenetic aberration </plain></SENT>
</text></document>